VAN DER HORST EDWARD (Chief Scientific Officer) reported 1 transaction at FAETH THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/16/2024ACC: 0001415889-24-004236
Officer· Chief Scientific Officer
Since Dec 2022
+212.26K
Net shares
Net buyer
$2.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
215.10K acquired · 2.84K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.84K
Price / share
$0.79
Trade value
$2.25K
% of position
4.8%
2/15/2024
58.91K→56.07K
Total
Net shares
−2.84K
Net value
-$2.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2024 | F · Tax Withholding | −2.84K | $0.79 | $2.25K | 4.8% | 58.91K | 56.07K |
| Total | −2.84K | -$2.25K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
125K shares
Shares
+125K
Strike price
0.79
Held after
125K
Exercisable
—
2/15/2024
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
90.10K shares
Shares
+90.10K
Strike price
0.79
Held after
90.10K
Exercisable
—
2/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock125K shares | 2/15/2024 | A · Award | +125K | 0.79 | — | 125K |
| Stock Option (Right to Buy) Direct | Common Stock90.10K shares | 2/15/2024 | A · Award | +90.10K | 0.79 | — | 90.10K |